{"id":21406,"date":"2021-03-01T19:28:00","date_gmt":"2021-03-01T12:28:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2021030119280021406"},"modified":"2021-03-01T21:38:41","modified_gmt":"2021-03-01T13:38:41","slug":"%e4%b8%89%e7%94%9f%e5%9b%bd%e5%81%a5601a%ef%bc%88%e7%9c%bc%e7%a7%91%ef%bc%89rvo%e9%a1%b9%e7%9b%ae%e5%ae%8c%e6%88%90%e9%a6%96%e4%be%8b%e5%8f%97%e8%af%95%e8%80%85%e5%85%a5%e7%bb%84","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2021030119280021406","title":{"rendered":"\u4e09\u751f\u56fd\u5065601A\uff08\u773c\u79d1\uff09RVO\u9879\u76ee\u5b8c\u6210\u9996\u4f8b\u53d7\u8bd5\u8005\u5165\u7ec4"},"content":{"rendered":"

\u4e0a\u6d772021\u5e743\u67081\u65e5 \/\u7f8e\u901a\u793e\/ — \u4e2d\u56fd\u6297\u4f53\u836f\u7269\u5148\u884c\u8005\u4e09\u751f\u56fd\u5065\u836f\u4e1a\uff08\u4e0a\u6d77\uff09\u80a1\u4efd\u6709\u9650\u516c\u53f8(688336.SH)\u4eca\u5929\u5ba3\u5e03\uff0c\u516c\u53f8\u81ea\u4e3b\u7814\u53d1\u7684\u91cd\u7ec4\u6297VEGF\u4eba\u6e90\u5316\u5355\u514b\u9686\u6297\u4f53\uff08\u7814\u53d1\u4ee3\u53f7\uff1a601A\uff09\uff0c\u76ee\u524d\u6b63\u5728\u8fdb\u884c\u201c\u8bc4\u4ef7601A\uff08\u773c\u79d1\uff09\u5728\u89c6\u7f51\u819c\u5206\u652f\u9759\u8109\u963b\u585e(BRVO)\/\u4e2d\u592e\u9759\u8109\u963b\u585e(CRVO)\u6240\u81f4\u9ec4\u6591\u6c34\u80bf\u75c5\u53d8\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u7684\u591a\u4e2d\u5fc3\u3001\u968f\u673a\u3001\u53cc\u76f2\u3001\u9633\u6027\u836f\u7269\u5bf9\u7167\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u201d\u3002\u65e5\u524dBRVO\u548cCRVO\u4e24\u4e2a\u9879\u76ee\u5df2\u5206\u522b\u987a\u5229\u5b8c\u6210\u9996\u4f8b\u53d7\u8bd5\u8005\u5165\u7ec4\u3002<\/p>\n

\u89c6\u7f51\u819c\u9759\u8109\u963b\u585e(Retinal vein occlusion, <\/span>RVO)\u662f\u773c\u79d1\u7b2c\u4e8c\u5927\u5e38\u89c1\u7684\u89c6\u7f51\u819c\u8840\u7ba1\u6027\u75be\u75c5\uff0c\u60a3\u8005\u901a\u5e38\u56e0\u4e3a\u7ee7\u53d1\u9ec4\u6591\u6c34\u80bf\u800c\u5bfc\u81f4\u4e25\u91cd\u89c6\u529b\u4e0b\u964d\u3002\u6839\u636e\u5176\u963b\u585e\u90e8\u4f4d\u4e0d\u540c\uff0c\u89c6\u7f51\u819c\u9759\u8109\u963b\u585e\u53ef\u5206\u4e3a\u89c6\u7f51\u819c\u5206\u652f\u9759\u8109\u963b\u585e(Branch retinal vein occlusion, <\/span>BRVO)\u548c\u89c6\u7f51\u819c\u4e2d\u592e\u9759\u8109\u963b\u585e(Central retinal vein occlusion, <\/span>CRVO)\uff0c\u5176\u60a3\u75c5\u7387\u5206\u522b\u4e3a0.1%~0.4%\u548c 0.6%~1.6%\u3002\u89c6\u7f51\u819c\u9759\u8109\u963b\u585e\u7684\u5e76\u53d1\u75c7\u6709\u9ec4\u6591\u6c34\u80bf\u3001\u89c6\u7f51\u819c\u53ca\u89c6\u76d8\u65b0\u751f\u8840\u7ba1\u5f62\u6210\u3001\u73bb\u7483\u4f53\u51fa\u8840\u53ca\u65b0\u751f\u8840\u7ba1\u6027\u9752\u5149\u773c\u7b49\uff0c\u5176\u4e2d\u9ec4\u6591\u6c34\u80bf\u662f RVO \u5bfc\u81f4\u89c6\u529b\u4e0b\u964d\u6700\u4e3b\u8981\u7684\u539f\u56e0<\/span>\uff0c\u4e5f\u662f\u5176\u6700\u5e38\u89c1\u7684<\/span>\u5e76\u53d1\u75c7\uff0c\u53d1\u751f\u7387\u4e3a 48%~67%\u3002\u9ec4\u6591\u6c34\u80bf\u65e9\u671f\u75c5\u53d8\u5c31\u4f1a\u5bf9\u60a3\u8005\u7684\u89c6\u529b\u4ea7\u751f\u4e0d\u826f\u5f71\u54cd\uff0c\u4e25\u91cd\u6216\u957f\u671f\u7684\u9ec4\u6591\u6c34\u80bf\u4f1a\u9020\u6210\u6c38\u4e45\u6027\u89c6\u529b\u635f\u5bb3\u3002\u82e5\u80fd\u5728\u9ec4\u6591\u6c34\u80bf\u65e9\u671f\u75c5\u53d8\u65f6\u4f7f\u6c34\u80bf\u5c3d\u5feb\u6d88\u9000\uff0c\u5219\u60a3\u8005\u7684\u89c6\u529b\u4f1a\u5f97\u5230\u4e0d\u540c\u7a0b\u5ea6\u7684\u6062\u590d\u3002<\/p>\n

\u5728\u5df2\u7ecf\u5b8c\u6210\u7684\u4e24\u9879I\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0c\u5305\u62ec\u5e74\u9f84\u76f8\u5173\u6027\u9ec4\u6591\u53d8\u6027(AMD)\u548c\u7cd6\u5c3f\u75c5\u9ec4\u6591\u6c34\u80bf(DME)\u75c5\u4eba\u5355\u5242\u91cf\u548c\u591a\u5242\u91cf\u722c\u5761\u8bd5\u9a8c\uff0c601A\u663e\u793a\u51fa\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u5e76\u53ef\u4e0d\u540c\u7a0b\u5ea6\u5730\u6539\u5584\u60a3\u8005\u89c6\u529b\uff0c\u63d0\u9ad8\u60a3\u8005\u751f\u6d3b\u8d28\u91cf\u3002<\/p>\n

\u4e09\u751f\u56fd\u5065\u8463\u4e8b\u957f\u5a04\u7ade\u535a\u58eb\u8868\u793a\uff1a\u201c\u6211\u4eec\u5f88\u9ad8\u5174601A\uff08\u773c\u79d1\uff09RVO\u9879\u76ee\u5b8c\u6210\u9996\u4f8b\u53d7\u8bd5\u8005\u5165\u7ec4\u3002\u4e09\u751f\u56fd\u5065\u5c06\u7ee7\u7eed\u52a0\u5feb\u63a8\u8fdb\u8be5\u4ea7\u54c1\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002\u671f\u5f85601A\u65e9\u65e5\u6210\u529f\u5f00\u53d1\u7528\u4e8e\u6cbb\u7597\u773c\u5e95\u65b0\u751f\u8840\u7ba1\u6027\u75be\u75c5\uff0c\u4e3a\u4e34\u5e8a\u533b\u751f\u548c\u773c\u5e95\u75c5\u60a3\u8005\u5e26\u6765\u798f\u97f3\u3002\u201d<\/p>\n

\u76f8\u5173\u94fe\u63a5 :<\/p>\n

http:\/\/www.3s-guojian.com<\/p>\n","protected":false},"excerpt":{"rendered":"

\u4e0a\u6d772021\u5e743\u67081\u65e5 \/\u7f8e\u901a\u793e\/ — \u4e2d\u56fd\u6297\u4f53\u836f\u7269\u5148\u884c\u8005\u4e09\u751f\u56fd\u5065\u836f\u4e1a\uff08\u4e0a\u6d77\uff09\u80a1\u4efd\u6709\u9650\u516c\u53f8(688336.SH)\u4eca\u5929\u5ba3\u5e03\uff0c\u516c\u53f8\u81ea\u4e3b\u7814\u53d1\u7684\u91cd\u7ec4\u6297VEGF\u4eba\u6e90\u5316\u5355\u514b\u9686\u6297\u4f53\uff08\u7814\u53d1\u4ee3\u53f7\uff1a601A\uff09\uff0c\u76ee\u524d\u6b63\u5728\u8fdb\u884c\u201c\u8bc4\u4ef7601A\uff08\u773c\u79d1\uff09\u5728\u89c6\u7f51\u819c\u5206\u652f\u9759\u8109\u963b\u585e(BRVO)\/\u4e2d\u592e\u9759\u8109\u963b\u585e(CRVO)\u6240\u81f4\u9ec4\u6591\u6c34\u80bf\u75c5\u53d8\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u7684\u591a\u4e2d\u5fc3\u3001\u968f\u673a\u3001\u53cc\u76f2\u3001\u9633\u6027\u836f\u7269\u5bf9\u7167\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u201d\u3002\u65e5\u524dBRVO\u548cCRVO\u4e24\u4e2a\u9879\u76ee\u5df2\u5206\u522b\u987a\u5229\u5b8c\u6210\u9996\u4f8b\u53d7\u8bd5\u8005\u5165\u7ec4\u3002 \u89c6\u7f51\u819c\u9759\u8109\u963b\u585e(Retinal vein occlusion, RVO)\u662f\u773c\u79d1\u7b2c\u4e8c\u5927\u5e38\u89c1\u7684\u89c6\u7f51\u819c\u8840\u7ba1\u6027\u75be\u75c5\uff0c\u60a3\u8005\u901a\u5e38\u56e0\u4e3a\u7ee7\u53d1\u9ec4\u6591\u6c34\u80bf\u800c\u5bfc\u81f4\u4e25\u91cd\u89c6\u529b\u4e0b\u964d\u3002\u6839\u636e\u5176\u963b\u585e\u90e8\u4f4d\u4e0d\u540c\uff0c\u89c6\u7f51\u819c\u9759\u8109\u963b\u585e\u53ef\u5206\u4e3a\u89c6\u7f51\u819c\u5206\u652f\u9759\u8109\u963b\u585e(Branch retinal vein occlusion, BRVO)\u548c\u89c6\u7f51\u819c\u4e2d\u592e\u9759\u8109\u963b\u585e(Central retinal vein occlusion, CRVO)\uff0c\u5176\u60a3\u75c5\u7387\u5206\u522b\u4e3a0.1%~0.4%\u548c 0.6%~1.6%\u3002\u89c6\u7f51\u819c\u9759\u8109\u963b\u585e\u7684\u5e76\u53d1\u75c7\u6709\u9ec4\u6591\u6c34\u80bf\u3001\u89c6\u7f51\u819c\u53ca\u89c6\u76d8\u65b0\u751f\u8840\u7ba1\u5f62\u6210\u3001\u73bb\u7483\u4f53\u51fa\u8840\u53ca\u65b0\u751f\u8840\u7ba1\u6027\u9752\u5149\u773c\u7b49\uff0c\u5176\u4e2d\u9ec4\u6591\u6c34\u80bf\u662f RVO \u5bfc\u81f4\u89c6\u529b\u4e0b\u964d\u6700\u4e3b\u8981\u7684\u539f\u56e0\uff0c\u4e5f\u662f\u5176\u6700\u5e38\u89c1\u7684\u5e76\u53d1\u75c7\uff0c\u53d1\u751f\u7387\u4e3a 48%~67%\u3002\u9ec4\u6591\u6c34\u80bf\u65e9\u671f\u75c5\u53d8\u5c31\u4f1a\u5bf9\u60a3\u8005\u7684\u89c6\u529b\u4ea7\u751f\u4e0d\u826f\u5f71\u54cd\uff0c\u4e25\u91cd\u6216\u957f\u671f\u7684\u9ec4\u6591\u6c34\u80bf\u4f1a\u9020\u6210\u6c38\u4e45\u6027\u89c6\u529b\u635f\u5bb3\u3002\u82e5\u80fd\u5728\u9ec4\u6591\u6c34\u80bf\u65e9\u671f\u75c5\u53d8\u65f6\u4f7f\u6c34\u80bf\u5c3d\u5feb\u6d88\u9000\uff0c\u5219\u60a3\u8005\u7684\u89c6\u529b\u4f1a\u5f97\u5230\u4e0d\u540c\u7a0b\u5ea6\u7684\u6062\u590d\u3002 \u5728\u5df2\u7ecf\u5b8c\u6210\u7684\u4e24\u9879I\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0c\u5305\u62ec\u5e74\u9f84\u76f8\u5173\u6027\u9ec4\u6591\u53d8\u6027(AMD)\u548c\u7cd6\u5c3f\u75c5\u9ec4\u6591\u6c34\u80bf(DME)\u75c5\u4eba\u5355\u5242\u91cf\u548c\u591a\u5242\u91cf\u722c\u5761\u8bd5\u9a8c\uff0c601A\u663e\u793a\u51fa\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u5e76\u53ef\u4e0d\u540c\u7a0b\u5ea6\u5730\u6539\u5584\u60a3\u8005\u89c6\u529b\uff0c\u63d0\u9ad8\u60a3\u8005\u751f\u6d3b\u8d28\u91cf\u3002 \u4e09\u751f\u56fd\u5065\u8463\u4e8b\u957f\u5a04\u7ade\u535a\u58eb\u8868\u793a\uff1a\u201c\u6211\u4eec\u5f88\u9ad8\u5174601A\uff08\u773c\u79d1\uff09RVO\u9879\u76ee\u5b8c\u6210\u9996\u4f8b\u53d7\u8bd5\u8005\u5165\u7ec4\u3002\u4e09\u751f\u56fd\u5065\u5c06\u7ee7\u7eed\u52a0\u5feb\u63a8\u8fdb\u8be5\u4ea7\u54c1\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002\u671f\u5f85601A\u65e9\u65e5\u6210\u529f\u5f00\u53d1\u7528\u4e8e\u6cbb\u7597\u773c\u5e95\u65b0\u751f\u8840\u7ba1\u6027\u75be\u75c5\uff0c\u4e3a\u4e34\u5e8a\u533b\u751f\u548c\u773c\u5e95\u75c5\u60a3\u8005\u5e26\u6765\u798f\u97f3\u3002\u201d \u76f8\u5173\u94fe\u63a5 : http:\/\/www.3s-guojian.com… Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":8278,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-21406","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/21406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=21406"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/21406\/revisions"}],"predecessor-version":[{"id":21407,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/21406\/revisions\/21407"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/8278"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=21406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=21406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=21406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}